By Alexandra Perez
Learn more about Christopher Missling, PhD, on LinkedIn and explore Anavex Life Sciences’ groundbreaking work at their website.
In the ongoing battle against neurodegenerative diseases like Alzheimer’s and Parkinson’s, Christopher U. Missling, PhD, President and CEO of Anavex Life Sciences Corp., has emerged as a trailblazer. With a focus on precision medicine, Dr. Missling leads a company that is redefining what’s possible in central nervous system (CNS) healthcare through novel potential therapies targeting the potential root causes of these debilitating conditions.
